About Steve Swann
Steve Swann is the Chief Scientific Officer with over 20 years of experience in computational technology marketing, having held leadership roles at Schrödinger, Iktos, and ProCeryon Biosciences.
Known information
Steve Swann serves as the Chief Scientific Officer, bringing more than two decades of expertise in developing and deploying marketing strategies for computational technologies. He has an impressive background with previous positions at notable companies such as Schrödinger and Iktos. At Iktos, he excelled as the Senior Vice President and Head of US Operations, and at Schrödinger, he was the Vice President of Strategic Business. Additionally, Swann has contributed his expertise as a Strategic Business Advisor to Nanome. He is also the co-founder, President, and CEO of ProCeryon Biosciences. His academic credentials include a B.S. degree Magna Cum Laude in Physics from the University of Pavia, Italy, and a Ph.D. in Theoretical Physics from the Rockefeller University.
About TandemAI
TandemAI provides an integrated drug discovery platform combining AI and physics-based tools, aimed at democratizing access to advanced drug discovery technologies. The company recently raised $35 million in Series A financing to enhance its computational and experimental capabilities.